LONA Financials

Income Statement
MetricQ2 2026Q1 2026
Revenue
0
0
Cost of Revenue
0
0
Gross Profit
0
0
Operating Expenses
19.5M
+13.0%
17.2M
R&D
12.7M
+12.8%
11.3M
SG&A
6.6M
-4.4%
6.9M
Operating Income
-19453000
-13.0%
-17214000
EBITDA
-19226000
-13.2%
-16983000
Net Income
-19007000
+42.3%
-32957000
EPS (Basic)
$-0.80
+53.8%
$-1.73
EPS (Diluted)
$-0.80
+53.8%
$-1.73
Shares (Diluted)
23.7M
+24.7%
19.0M
LeonaBio (LONA) โ€” Financials